Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Accounts Payable Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Accounts Payable
$6.8m
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Accounts Payable
ÂŁ14.2B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
7%
AstraZeneca PLC
LSE:AZN
Accounts Payable
$20.5B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
7%
Indivior PLC
LSE:INDV
Accounts Payable
$46m
CAGR 3-Years
19%
CAGR 5-Years
13%
CAGR 10-Years
-1%
Hikma Pharmaceuticals PLC
LSE:HIK
Accounts Payable
$541m
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
16%
Dechra Pharmaceuticals PLC
LSE:DPH
Accounts Payable
ÂŁ144.5m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
18%

See Also

What is Verona Pharma PLC's Accounts Payable?
Accounts Payable
6.8m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Accounts Payable amounts to 6.8m USD.

What is Verona Pharma PLC's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
-14%

Over the last year, the Accounts Payable growth was 730%.

Back to Top